This preview shows pages 1–2. Sign up to view the full content.
This preview has intentionally blurred sections. Sign up to view the full version.View Full Document
Unformatted text preview: degree of cross protection (getting protected for things other than what the vaccination targets) and lastly, there is the question of the vaccine protecting men. The reason this vaccination works well with females is because the serum antibodies induced by VLP vaccination are extensively transudated into cervical mucus. (Lowy) But this would be less applicable to men because their gentiles are not mucosal. This vaccination is still being studied, and the article suggests that many people will not be able to afford this because it involves a follow up and they are expensive for some. Therefore, this will most likely benefit the next generation of women. Citations Schiller, John and Lowly, Douglas. "Prospects for Cervical Cancer Prevention by Human Papillomavirus Vaccination." Laboratory of Cellular Oncology Nov1,2006 <www.aacrjournals.org>....
View Full Document